{
    "nct_id": "NCT03817398",
    "official_title": "Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)",
    "inclusion_criteria": "* Patient must have been diagnosed with CML-CP at < 18 years of age.\n* Patient must have histologic verification of CML-CP at original diagnosis\n* Patient must be in molecular remission (MR) with a BCR-ABL1 level of =< 0.01% BCR-ABL1 as measured using the International Scale (IS) by RQ-PCR for >= 2 consecutive years at the time of enrollment\n\n  * Please note: The lab evaluating disease status and molecular response for this study must be College of American Pathology (CAP) and/or Clinical Laboratory Improvement Amendments (CLIA) certified (United States [US] only), sites in other countries must be certified by their accredited authorities. All labs must use the International Scale guidelines with a sensitivity of detection assay =< 0.01% BCR-ABL1 and be able to report results in =< 2 weeks\n* Patient must have received any TKI for a minimum of 3 consecutive years at time of enrollment\n* Patient agrees to discontinue TKI therapy\n* REGULATORY REQUIREMENTS\n* All patients and/or their parents or legal guardians must sign a written informed consent\n* All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met\n* ELIGIBILITY FOR PATIENT-REPORTED OUTCOMES (PROs):\n* Age >= 8 years at the time of enrollment\n* Ability to understand English or Spanish\n* Cognitive ability to complete instruments according to the primary team\n* ELIGIBILITY FOR AAML18P1 NEUROCOGNITIVE STUDY:\n* Patient must be 5 years or older at the time of enrollment\n* English-, French- or Spanish-speaking\n* No known history of neurodevelopmental disorder prior to diagnosis of CML (e.g., Down syndrome, Fragile X, William syndrome, mental retardation)\n* No significant visual or motor impairment that would prevent computer use or recognition of visual test stimuli\nHealthy volunteers allowed\nMust have maximum age of 25 Years",
    "exclusion_criteria": "* Known T3151 mutation\n* Additional clonal chromosomal abnormalities in Philadelphia chromosome (Ph) positive (+) cells at any time prior to enrollment that include \"major route\" abnormalities (second Ph, trisomy 8, isochromosome 17q, trisomy 19), complex karyotype or abnormalities of 3q26.2\n* History of accelerated phase or blast crisis CML\n* Female patients who are pregnant\n* Lactating females are not eligible unless they have agreed not to breastfeed their infants\n* Female patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained",
    "miscellaneous_criteria": ""
}